Sola Security Launches Lumina, an Autonomous Security Deep Research Platform for Actionable Risk Intelligence Rekt Raccoons: NFT Character Collection to be Used in a Metaverse Play to Earn Game
Rekt Raccoons, as they are called, comprise 9968 unique and randomly generated NFT Art Pieces….
From VoIP to CPaaS – Shifts in the Cloud Communications Market and Future Outlooks | An Analysis By Nextiva
The cloud communications sector is growing rapidly due to pandemic-accelerated trends towards remote work, and…
Terminus Group Inaugurates Its MENA Headquarters in Dubai
Dubai, UAE / ACCESSWIRE / September 23, 2021 / Terminus Group has officially inaugurated its…
Hungarian railway company successfully relies on USU Software Asset Management
MÁV-Volán Group uses the USU solution for financial management of its software licenses Möglingen, Germany…
Bavarian Nordic’s COVID-19 Funding Agreement with the Danish Ministry of Health Receives Final Approval from Parliament
COPENHAGEN, Denmark, September 24, 2021 – Bavarian Nordic A/S (OMX: BAVA) announced today that the…
Algenex’ CrisBio® platform validated by EU and UK marketing authorization for CrisBio-based vaccine for Rabbit Viral Haemorrhagic Disease
PRESS RELEASE Algenex’ CrisBio® platform validated by EU and UK marketing authorization for CrisBio-based vaccine…
Sanofi: Availability of the Q3 2021 Memorandum for modelling purposes
Availability of the Q3 2021 Memorandum for modelling purposes Paris, France – September…
Roche presents new data at World Muscle Society (WMS) 2021 highlighting new advances for people living with rare neuromuscular disorders
New data show pre-symptomatic babies with spinal muscular atrophy (SMA) treated with Evrysdi maintained the…
Medicenna Appoints Dr. John H. Sampson to its Board of Directors
Announces Results of Annual Meeting of Shareholders TORONTO and HOUSTON, Sept. 23, 2021 (GLOBE NEWSWIRE)…
vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects Results…
Ocugen, Inc. to Participate in Fireside Chat at the Cantor Virtual Global Healthcare Conference
MALVERN, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused…
IGM Biosciences to Present at the 2021 Cantor Virtual Global Healthcare Conference
MOUNTAIN VIEW, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a…
Entasis Therapeutics to Participate in the Cantor Fitzgerald Virtual Global Healthcare Conference
WALTHAM, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a…
Paratek Pharmaceuticals Presenting New Data for NUZYRA® (omadacycline) at IDWeek 2021
Key highlights include real-world health outcomes data for pneumonia and skin infections, data on in…
Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
SAN JOSE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics (Nasdaq: RANI), a clinical…
AGTC Provides Financial Results for the Fourth Quarter and Year Ended June 30, 2021
-Data from ongoing clinical trials in XLRP and ACHM shows evidence of clinical activity and…
SELLAS Life Sciences Announces Settlement of Derivative Litigation
NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.
DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (NASDAQ: SBBP) (the…
Viridian Therapeutics Announces Closing of Public Offering of Shares of Common Stock and Preferred Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
WALTHAM, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical…
SeqLL Announces Publication of a New Single-Cell Epitranscriptomic Method Powered by SeqLL’s tSMS® Platform
Method developed by leading researchers at the Bernstein Laboratory and SeqLL Inc. Funding for the…